Wegovy users have five times greater risk of sudden sight loss than Ozempic users, study finds

‘Eye strokes’ that reduce blood flow to optic nerve likely to be side-effect of active ingredient semaglutide, says authorPatients taking Wegovy have nearly five times the risk of sudden sight loss of those on Ozempic, a large-scale study has found.Glucagon-like peptide-1 ...

🔗 Read more: https://www.theguardian.com/society/2026/mar/10/wegovy-sudden-sight-loss-ozempic-study-semaglutide

#News #Health #Medicine #Software #Policy #WorldNews